![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 42, 29720-29725, October 15, 1999
From the Departments of Methionine adenosyltransferase (MAT) catalyzes
the synthesis of S-adenosylmethionine (AdoMet). The
mammalian MAT II isozyme consists of catalytic Methionine adenosyltransferase
(MAT)1
(ATP:L-methionine S-adenosyltransferase) (EC 2.5.1.6)
catalyzes the biosynthesis of S-adenosylmethionine (AdoMet)
from L-methionine (L-Met) and ATP (1). AdoMet
is the major methyl donor in transmethylation reactions, including the
methylation of DNA, RNA, proteins, and other small molecules. Further,
AdoMet is the propylamine donor in the biosynthesis of polyamines
(2-5), and it participates as a co-factor in key metabolic pathways
(6-8). Inasmuch as AdoMet plays a pivotal role in metabolism, it is
not surprising that most species studied to date have more than one MAT
isozyme (3).
Mammalian MAT exists in multiple forms that differ in their physical
and kinetic properties among distinct species and even among different
tissues of the same species. In mammals there are three forms,
designated MAT I, II, and III, that differ in their tissue distribution
and kinetic properties (7, 9-11). MAT I and III are referred to as the
hepatic forms because their expression is confined to the liver. By
contrast, MAT II is found in all mammalian tissues that have been
examined to date, including erythrocytes, lymphocytes, brain, kidney,
testis, and liver (10, 12-18). MAT I is a tetramer and MAT III is a
dimer of an identical catalytic subunit, Previous studies had shown that physiological activation of human
lymphocytes induces down-regulation of the Cell Culture
The COS-1 cells (African green monkey kidney fibroblasts, ATCC
CRL 1650) were cultured in Dulbecco's modified Eagle's medium (Life
Technologies, Inc.) supplemented with 10% heat-inactivated fetal
bovine serum (Atlanta Biologicals) and 10 mM
L-glutamine (Cellgro).
Cloning of MAT II The full-length cDNA encoding human lymphocyte (HuLy) MAT II
Transfection of COS-1 Cells
Transfection of COS-1 cells with pTargeT/MAT2A or
pTargeT/MAT2B was done using the cationic lipid reagent,
Transfast (Promega). Preliminary experiments were carried out to
optimize the transfection conditions. Typically, 1.5 × 106 cells were plated in a 100-mm dish 1 day prior to
transfection. For each plate, 15 µg of vector DNA was mixed with
Transfast at a ratio of 1:1 and incubated in a protein-free medium for
2 h. For cells co-transfected with both Analysis of Expressed MAT II Western Blot--
Extracts from normal, mock-transfected, and
Kinetic Properties of Expressed MAT II Subunits--
MAT
activity in cell extracts was assayed as described previously (13). The
assay mixture contained 5 mM ATP, 50 mM KCl, 15 mM MgCl2, 0.3 mM EDTA, 4 mM DTT in 50 mM TES buffer, pH 7.4). The
concentration of L-Met was varied between 2 and 80 µM using 14C-L-Met (57.9 mCi/mmol) to a concentration of up to 20 µM and supplementary with cold L-Met for higher concentrations.
Enzyme velocity is expressed as units/ml or units/mg protein, where 1 unit is defined as the formation of 1 nmol of AdoMet in 1 h.
Calculation of Km and Vmax
was also done using the PSI-plot software (Poly Software International)
and the Marquardt algorithm.
Analysis of the Expressed MAT II Experiments were designed to determine whether the expressed
Analysis by Native Gel Electrophoresis--
Cell extracts were
separated on 6% polyacrylamide gel in 1.5 M Tris, pH 8.8, under native conditions (without SDS). After blotting onto
nitrocellulose membrane, the blots were probed with anti- Analysis by Nickel-Agarose Bead Affinity Capture--
The
association between the His-tagged Separation of Recombinant and Endogenous MAT II Subunits from
COS-1 Cell Extracts and Determination of AdoMet Feedback Inhibition of
Enzyme Activity
Experiments were designed to test the effect of Detection and Kinetic Analysis of rMAT II Detection and Kinetic Analysis of MAT II Co-expression of MAT II Evidence for Association of MAT II
Second, we took advantage of the selective His tag on the
r
Together, the data provide evidence that the r Kinetic Analysis of MAT in Extracts from COS-1 Cells Co-expressing
rMAT II
Next we investigated whether the The essential role of AdoMet in cellular metabolism is underscored
by the fact that it participates in as many reactions as ATP and
regulates the function of many key molecules and pathways (2, 3, 5, 6).
It follows that understanding the regulation of synthesis of this
pivotal compound is important. AdoMet is synthesized by MAT, which in
mammalian cells exists as at least two isozymes; MAT I/III are confined
to hepatic tissue, and MAT II is found in all tissues (3, 5). An
emerging theme in the regulation of MAT activity in mammalian cells is
that the differential oligomerization of the enzyme subunits can
profoundly alter the enzyme physical properties, activity, and kinetic
regulation. For example, the Unlike the hepatic forms of MAT, MAT II, which is present in all
mammalian tissues, consists of nonidentical subunits In this study, we provide evidence that the Together, the data provide evidence that the MAT II The findings in this study provide a possible explanation for our
recent observation that down-regulation of In conclusion, the data reported here show that the association of MAT
II *
This work was supported by National Institutes of Health
Grant GM-54892-08 and Merit Review Award Funds from Veterans Affairs.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
**
To whom correspondence should be addressed: University of
Tennessee, Memphis, 956 Court Ave. Suite A-202, Memphis, TN 38163. Tel.: 901-448-7247; Fax: 901-448-7208; E-mail: Mkotb@utmem1.
utmem.edu.
2
H. L. LeGros, A.-B. Halim, A. Geller, and
M. Kotb, submitted for publication.
The abbreviations used are:
MAT, methionine
adenosyltransferase;
rMAT, recombinant MAT;
r
Expression and Functional Interaction of the Catalytic and
Regulatory Subunits of Human Methionine Adenosyltransferase in
Mammalian Cells*
§,
§,
§
**
Surgery,
Microbiology
and Immunology, and ¶ Biochemistry, University of Tennessee,
Memphis, Tennessee 38104 and the § Veterans Affairs Medical
Center, Memphis, Tennessee 38104
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
2 and
regulatory
subunits. The aim of this study was to investigate the
interaction and kinetic behavior of the human MAT II subunit proteins
in mammalian cells. COS-1 cells were transiently transfected with
pTargeT vector harboring full-length cDNA that encodes for the MAT
II
2 or
subunits. Expression of the His-tagged
recombinant
2 (r
2) subunit in COS-1 cells
markedly increased MAT II activity and resulted in a shift in the
Km for L-methionine (L-Met)
from 15 µM (endogenous MAT II) to 75 µM
(r
2), and with the apparent existence of two kinetic
forms of MAT in the transfected COS-1 cell extracts. By contrast,
expression of the recombinant
(r
) subunit had no effect on the
Km for L-Met of the endogenous MAT II, while it did cause an increase in both the Vmax
and the specific activity of endogenous MAT. Co-expression of both
r
2 and r
subunits resulted in a significant increase
of MAT specific activity with the appearance of a single kinetic form
of MAT (Km = 20 µM). The recombinant
MAT II
2 and r
subunit associated spontaneously either in cell-free system or in COS-1 cells co-expressing both subunits. Analysis of nickel-agarose-purified His-tagged
r
2 subunit from COS-1 cell extracts showed that the
subunit co-purified with the
2 subunit. Furthermore, the
2 and
subunits co-migrated in native polyacrylamide
gels. Together, the data provide evidence for
2 and
MAT subunit association. In addition, the
subunit regulated MAT II
activity by reducing its Km for L-Met and by rendering the enzyme more susceptible to feedback inhibition by
AdoMet. We believe that the previously described differential expression of MAT II
subunit may be an important mechanism by which
MAT activity can be modulated to provide different levels of AdoMet
that may be required at different stages of cell growth and differentiation.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1, encoded by
the MATIA gene (7, 19-22). On the other hand MAT II from
leukemic T cells or from activated human lymphocytes is a
hetero-oligomer that consists of
2 (53 kDa),
'2 (51 kDa) and
(38 kDa) subunits (13). The
2 and
'2 are the catalytic subunits,
whereas
appeared to have a regulatory function
(23-25).2 The
2 and
'2 subunits are immunologically
cross-reactive and essentially identical to each other but are quite
different from the
subunit. The
2 subunit, which
appears to be post-translationally processed to yield
'2
(13), is encoded by the MAT2A gene, which is homologous but
different from MAT1A gene (11, 19, 24).
subunit with coincidental alterations in MAT II kinetic properties (25). We
hypothesized that this differential expression of the
subunit may
be an important physiological mechanism by which MAT II activity can be
modulated. To test this hypothesis, we cloned and expressed both the
r
2 (24) and r
subunits2 of human MAT II
in COS-1 cells, where mammalian post-translational events may affect
subunit association and/or enzyme activity. In this study, we provide
evidence for the association of MAT II
2 and
subunits with consequent changes in enzyme kinetic and regulatory
properties. We believe that this is an important mechanism by which
AdoMet levels are controlled during cell growth and differentiation.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
2 and
Subunits cDNA into
Mammalian Expression Vectors
2 protein (24)2 was cloned into the pQE30 vector
(Qiagen) designed to express protein with an N-terminal six-histidine
(His) tag, and we introduced additional bases that encode for an
enterokinase site to allow removal of the tag. The HuLy MAT II
cDNA was cloned into the same expression vector without the
polyhistidine or the enterokinase site.2 The cloned
cDNAs encoding either the r
2 or the r
subunits
were transferred from the pQE30 vector to the mammalian expression pTargeT vector (Promega) to generate pTargeT/MAT2A and
pTargeT/MAT2B, respectively. Briefly, primers were designed
to amplify the full-length cDNA encoding either the
2 or the
subunits from the pQE30 vector. Amplification was done using Taq polymerase (Promega) and
pfu (Stratagene) in the ratio of 5:1, and the amplified
product containing an A-overhang was separated on 1% agarose gel in
0.5× TBE, purified, ligated into the mammalian expression vector,
pTargeT, and used to transform Escherichia coli strain JM109
competent cells by heat shock. Positive colonies were selected and
subcultured, and the plasmid DNA was purified (Qiagen). The purified
plasmid DNA was tested for the presence of the cloned inserts of the
correct size and orientation by both PCR and EcoRI
restriction site analysis. DNA from six colonies containing the proper
insert in the right direction were subjected to manual sequencing of
the entire cDNA in both directions using DNA cycle sequencing
reagents (Promega), and the sequence was compared with the previously
confirmed cDNA sequence for the
2 (24) or for the
subunit sequence2 to ensure that no mutations were
introduced during amplification. One representative clone for either
the
2 or the
subunit insert was grown for large
scale preparation of vector (Qiagen).
2 and
vectors, 12 µg of DNA from each was used. For each experiment, one
untransfected plate served as a normal control, and a second plate was
transfected with the pTargeT vector only (mock-transfected cells).
After 48 h, cells were harvested by trypsinization with a solution
containing 0.05% trypsin and 0.53 mM EDTA in Hanks'
balanced salt solution (from Cellgro), and the trypsinization was
stopped by the addition of media supplemented with 10% fetal calf
serum. The harvested cells were washed three times in 1 ml of Hanks'
balanced salt solution, counted, and then resuspended in 1× extraction
buffer containing protease inhibitors (50 mM Tris, pH 7.4, 100 mM NaCl, 5 mM MgCl2, 4 mM dithiothreitol, 0.1 IU/ml aprotinin, 0.5 µM phenylmethylsulfonyl fluoride, and 30 µg/ml soybean
trypsin inhibitor). Cells were lysed by three cycles of quick freezing
and thawing, and the lysate was clarified by centrifugation at
15,000 × g for 10 min at 4 °C. If not immediately
used, the cell extracts were stored at
80 °C. Protein assays were
performed using the bicinchoninic acid reagent (Sigma) following the
manufacturer's instructions.
2 and
Subunits
2- or
-transfected COS-1 cells were prepared as
described above, and 40 µg of protein from each cell extract were
loaded onto 7.5% SDS-polyacrylamide gel (SDS-PAGE) after 1:1 dilution
in 2× sample loading buffer (60 mM Tris, pH 6.8, 4% SDS,
5% 2-mercaptoethanol, and 5% glycerol) and boiling in a water bath
for 5 min. For 17 × 17-cm gel size, electrophoresis was started
at 100 V, and after the tracking dye left the stacking gel the current
was kept constant at 30 mA for the remainder of the run. The gel was
electroblotted onto a nitrocellulose membrane (Bio-Rad) for 1.5 h
at 400 mA. After blocking overnight in 6% nonfat dry milk in
Tris-buffered saline, the blot was sequentially incubated with primary
rabbit anti-
2 or anti-
antibodies prepared as
described previously (27, 28)2 followed by a secondary goat
anti-rabbit antibody conjugated to horseradish peroxidase (Southern
Biotechnology Associates, Inc.). The signal was initiated by the
chemiluminescence reagents (ECL, Amersham Pharmacia Biotech) and
detected using X-Omat film from Kodak. Molecular weight markers and
recombinant MAT II (rMAT II) subunit proteins purified for E. coli extracts were used to determine the migration of expressed
2 and
subunits.
2 and
Subunit
Interaction
2 and
subunits of MAT II associate and if their
association alters the kinetic properties of the enzyme. Two methods
were used to detect subunit association.
2 antibodies, stripped, and then reprobed with
anti-
antibodies. Overlapping signals were taken as an evidence for
co-migration of both subunits.
2 subunit and the
nontagged
subunit was analyzed by affinity purification on
nickel-agarose beads (Qiagen). In a 15-ml tube, 2 ml of the 50%
nickel-agarose slurry was spun down at 1000 rpm for 2 min, and then the
pellet was equilibrated with a buffer containing 300 mM
NaCl and 50 mM sodium phosphate, pH 8. Cellular extract
containing about 10 mg of proteins was added and incubated for 30 min
at 4 °C, with mixing on a vertical rotator. The equilibrated gel was
poured into the column and allowed to settle. The column was washed
several times with 5 ml of equilibration buffer until the absorbance at
280 mm of the go-through material was undetectable. Bound proteins were
eluted with 5 ml of 300 mM imidazole, dialyzed against 20 mM Tris, pH 8, and lyophilized. The lyophilized proteins
were reconstituted in 25 mM Tris buffer, pH 8, and the
protein content was determined by the bicinchoninic acid reagent
(Sigma). Proteins (2 µg each) were analyzed by SDS-PAGE as described above.
subunit on
the feedback inhibition of MAT II (
2 subunit) by AdoMet.
However, due to association of r
2 with endogenous
, as well as
the association of the r
with the endogenous
2 protein, it was
necessary to purify the subunits away from each other and to test them
separately and in combination for kinetic properties and inhibition by
AdoMet. Protein extracts from COS-1 cells co-expressing
2 and
subunits was fractionated on nickel-agarose
column (Qiagen) as described above. The purified proteins were loaded
onto a preparative 7.5% SDS-PAGE and after the separation was
complete, and the protein bands were visualized by impregnation in cold
300 mM KCl. The
2 or
bands were excised,
and proteins were electroeluted from the gel separately into
Tris-glycine buffer, pH 8, and dialyzed against 10 mM
ammonium bicarbonate and then lyophilized. The lyophilized subunits
were reconstituted, and the MAT assay was performed at 20 µM L-Met (as mentioned above) for
2 subunit alone or
2 plus
subunits
(combined at a molar ratio of 1:1) in the absence or in the presence of
25-50 µM AdoMet.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
2 Subunit
Expressed in COS-1 Cells--
COS-1 cells were transfected with
pTargeT/MAT2A plasmid DNA. Protein extracts from
untransfected, mock-transfected, and MAT2A-transfected cells
were analyzed by Western blots. In untransfected and mock-transfected cells, small amounts of endogenous
2,
2',
and
subunits were detected (Fig. 1,
lanes 1 and 2); however, cells
transfected with pTargeT/MAT2A expressed abundant amounts of
the r
2 protein, which migrated with a higher molecular
weight due to the additional N-terminal polyhistidine tag and the
enterokinase site (Fig. 1, lane 3). To study the
effect of overexpression of r
2 on MAT kinetics, extracts
from untransfected and transfected cells were assayed for MAT activity
at different concentrations of L-Met ranging from 2 to 80 µM. Transfection with pTargeT/MAT2A caused a
2-3-fold increase in MAT specific activity compared with untransfected cells (50 versus 20 units/mg of protein). In addition,
expression of the r
2 affected the enzyme
Km for L-Met. MAT II in untransfected
and mock-transfected cells had Km of 15 and 16 µM, respectively (Fig. 2,
A and B), which are within the range found in
resting human lymphocytes (23, 25). However, in cells expressing high
levels of rMAT II
2 protein, two kinetic forms with
Km for L-Met of 17 and 75 µM could be discerned (Fig. 2C).

View larger version (43K):
[in a new window]
Fig. 1.
Expression of rMAT II
2 subunit in COS-1 cells. COS-1
cells were transfected with pTargeT/MAT2A vector DNA as
described under "Materials and Methods." The cells were harvested
after 48 h, the proteins were extracted, and 40 µg of protein
were applied to 7.5% SDS-PAGE. The separated proteins were
transblotted onto a nitrocellulose membrane, which was probed with
anti-MAT II
2 and
antibodies. Lane 1, untransfected COS-1 cells; lane 2,
mock-transfected cells; lane 3, MAT II
2-transfected cells. The expressed r
2
protein migrated at higher than the native
2, since it
contains an additional six His residues and an enterokinase site at the
N-terminal end.

View larger version (19K):
[in a new window]
Fig. 2.
Effect of overexpression of MAT II
2 on the enzyme kinetics in COS-1
cells. Cellular protein extracts from untransfected,
mock-transfected or pTargeT/MAT II2A-transfected COS-1 cells
were assayed for MAT activity as described under "Materials and
Methods," at different concentrations of L-Met. A
Lineweaver-Burk plot (1/v versus 1/[L-Met])
was generated. A, normal cells; B,
mock-transfected cells; C,
2
cDNA-transfected cells. Enzyme velocity is expressed as units/ml or
units/mg of protein, where 1 unit is defined as the formation of 1 nmol
of AdoMet in 1 h. Calculation of Km and
Vmax was also done using the PSI-plot software
(Poly Software International) and the Marquardt algorithm
Expressed in COS-1
Cells--
COS-1 cells were transfected with pTargeT/MAT2B
plasmid DNA, and the protein extracts from untransfected or transfected
cells were analyzed by Western blots. Cells transfected with
pTargeT/MAT2B expressed higher amounts of the r
protein
compared with untransfected cells (Fig.
3, inset). Expression of MAT
II
protein did not significantly affect the kinetic behavior of MAT
II in normal cells (Fig. 3) inasmuch as the Km for
L-Met was 20 µM; however, expression of r
caused an increase in Vmax and a ~2-fold increase in the MAT specific activity at different concentrations of
L-Met (35 versus 20 units/mg of protein).

View larger version (13K):
[in a new window]
Fig. 3.
Effect of overexpression of MAT II
on the enzyme kinetics in COS-1 cells.
Cellular protein extract from pTargeT/MATIIB-transfected
COS-1 cells was assayed for MAT activity as described under
"Materials and Methods," at different concentrations of
L-Met. Lineweaver-Burk plot (1/v versus 1/[L-methionine]) was used to calculate
Km. The velocity is expressed as units/ml, where 1 unit is defined as the formation of 1 nmol of AdoMet in 1 h.
Inset, expression of MAT II
subunit in COS-1 cells.
COS-1 cells were transfected with pTargeT/MAT2B vector DNA
as described under "Materials and Methods." Cells were harvested
after 48 h, proteins were extracted, and 40 µg were applied to
7.5% SDS-PAGE followed by transblotting onto nitrocellulose membrane,
which was probed with anti-MAT II
2 and
antibodies.
Lane 1, untransfected COS-1 cells;
lane 2,
cDNA-transfected cells.
2 and
Subunits--
COS-1 cells were co-transfected with
pTargeT/MAT2A and pTargeT/MAT2B plasmid DNA, and
the protein extracts from untransfected and transfected cells were
analyzed by Western blots. As shown in Fig.
4, the cells that were co-transfected
with both vectors expressed abundant amounts of the r
2
and r
proteins compared with untransfected or mock-transfected
cells.

View larger version (52K):
[in a new window]
Fig. 4.
Co-expression of rMAT II
2 and rMAT II
subunits in COS-1 cells. COS-1 cells were co-transfected
with pTargeT/MAT2A (with His tag and enterokinase site) and
pTargeT/MAT2B DNA as described under "Materials and
Methods." Cells were harvested after 48 h, proteins were
extracted, and 40 µg were applied to 7.5% SDS-PAGE followed by
transblotting onto nitrocellulose membrane, which was probed with
anti-MAT II
2 and
antibodies. Lane 1, untransfected COS-1 cells; lane 2,
2 and
cDNA-transfected cells.
2 and
Subunits--
The association between the
2 and
subunits was assessed by different means. First, extracts from COS-1
cells co-transfected with vectors encoding
2 and
subunits were subjected to PAGE gel separation under native conditions
and blotted onto a nitrocellulose membrane that was sequentially probed
with antibodies to r
2 followed by antibodies to the
subunit, with stripping in between the probing. Both antibodies
recognized the same bands on the transblot (Fig.
5), and this indicated the co-migration
of both subunits under native conditions.

View larger version (21K):
[in a new window]
Fig. 5.
Co-migration of MAT II
2 and
subunits on native PAGE. Forty micrograms of protein
extracts from untransfected normal or rMAT II
2- or
r
2
-expressing cells were applied to 6% native
polyacrylamide gel. The transblot was probed with antibody to the
r
2 protein (lane 1), developed
with ECL, stripped, and then reprobed with antibody to r
protein
(lane 2). A, untransfected cells;
B,
2-expressing cells; C,
2
-expressing cells.
2 subunit but not on the
subunit and used
nickel-agarose to affinity-purify the
2 subunit from
extracts of COS-1 cells co-expressing r
2 and r
subunits to test whether the
subunit associates with the
2 subunit. As shown in Fig.
6A, analysis of the protein
purified on nickel-agarose columns by SDS-PAGE showed that the r
subunit co-purified with the r
2 subunit. Interestingly,
when extracts from cells, which were individually expressing
r
2 or r
proteins, were simply mixed in a protein
ratio of 1:1, the
2 and
subunits also associated and
co-purified on the nickel-agarose column (Fig. 6B), thereby
indicating the spontaneous association of these proteins.

View larger version (62K):
[in a new window]
Fig. 6.
MAT II
2
and
subunits co-purify on nickel-agarose
gel. rMAT II
2, but not rMAT II
, was expressed
as a poly-His-tagged protein. Cellular protein extracts from
untransfected and
2-,
-, and
2
-transfected COS-1 cells were loaded onto
nickel-agarose columns. The captured proteins were eluted in 300 mM imidazole, dialyzed, and lyophilized. The reconstituted
proteins were applied to SDS-PAGE and transblotted onto nitrocellulose
membranes. Transblots were probed with anti-MAT II
2 and
antibodies. Fig. 6A, lane 1,
untransfected cell extract; lane 2, untransfected
cell extract after separation on nickel-agarose; lane 3,
2-expressing cell extract; lane 4,
2-expressing cell extract after separation
on nickel-agarose; lane 5,
-expressing cell
extract; lane 6,
-expressing cell extract
after separation on nickel-agarose; lane 7,
2
-co-expressing cell extract; lane 8,
2
-co-expressing cell extract after
separation on nickel-agarose columns. The same purification procedure
was followed for the mixed extracts from the
2-expressing cells and the
-expressing cells, and
this was followed by analysis on SDS-PAGE (Fig. 6B).
Lane 1,
2-expressing cell extract;
lane 2,
2-expressing cell extract
after separation on nickel-agarose; lane 3,
-expressing cell extract; lane 4,
-expressing cell extract after separation on nickel-agarose;
lane 5, mixed extracts from
2- and
-expressing cells; lane 6, mixed extracts from
2- and
-expressing cells after separation on
nickel-agarose column.
2 subunit
associates with the
subunit of MAT II. Interestingly, some of the native
2 and
2' subunits were also
captured by the His-tagged r
2 protein, suggesting
heterologous oligomerization of
2 and
2'
subunits with each other as well as with the
subunit.
2 and r
Subunits--
MAT activity was
assayed in extracts of COS-1 cells expressing r
2 only or
co-expressing both r
2 and r
subunits. MAT activity was increased by approximately 5-fold in the co-transfected cells as
compared with untransfected or mock-transfected cells (Fig. 7). Further, co-expression of r
subunit caused an increase in MAT activity over that found in cells
transfected with r
2 alone. The Km for
L-Met in extracts from COS-1 cells co-expressing both
subunits indicated the presence of a single kinetic form of MAT II with
Km of 20 µM (data not shown).

View larger version (26K):
[in a new window]
Fig. 7.
Effect of co-expression of MAT II
2 and
on MAT
specific activity in COS-1 cells. Cellular protein extracts were
assayed for MAT activity, as described under "Materials and
Methods," at different concentrations of L-Met.
Normal, untransfected COS-1 cells;
mock, mock-transfected;
,
2
cDNA-transfected;
,
cDNA-transfected;

,
2 cDNA- and
cDNA-co-transfected COS-1 cells. MAT activity is expressed as
units/mg of protein, where 1 unit is defined as the formation of 1 nmol
of AdoMet in 1 h.
subunit alters the feedback
inhibition of MAT II by the product, AdoMet. The activity of the
purified r
with and without r
was tested in the absence or in the
presence of AdoMet. To rule out the possible association of either
r
2 or r
subunits with the endogenous MAT II subunits, we performed nickel-agarose column purification of extracts from COS-1
cells co-transfected with both subunits, separated the products on
SDS-PAGE, excised the
2 and
bands from the gel,
electroeluted the protein, and purified each subunit separately. The
purified subunits were mixed in equimolar ratios, and assayed for MAT
activity in the presence and in the absence of AdoMet. While the
addition of the
subunit significantly increased the catalytic
activity of r
2 by almost 2-fold, the presence of the
subunit rendered the enzyme more susceptible to AdoMet inhibition, with
more than a 2-fold increase in the inhibitory effect of AdoMet
seen when
2 and
were combined (Fig.
8).

View larger version (21K):
[in a new window]
Fig. 8.
Effect of rMAT II
on the feedback inhibition of MAT II by AdoMet. The MAT
assay was conducted as described under "Materials and Methods," at
20 µM of L-Met. AdoMet was added at a final
concentration of 25 or 50 µM to rMAT II
2
in the absence or in the presence of the rMAT II
subunit.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1 catalytic subunit of the
hepatic form of MAT exists either as a dimer (MAT III) or a tetramer
(MAT I). This difference in oligomeric forms results in profound
changes in the hydrophobic properties of the enzyme; MAT I is
nonhydrophobic, whereas MAT III is strongly hydrophobic (7, 29).
Furthermore, MAT I is inhibited, while MAT III is activated by AdoMet,
and the Km for L-Met for these two forms
is 3-14 µM and 100-200 µM, respectively
(16, 23, 30, 31). Although several elegant studies (9, 29, 31-33) have
described means for the interconversion of MAT I and III, the
physiologic relevance of the need to have these two forms of MAT in the
liver remains unclear.
2
and
(13). Previously, we reported that the
2 subunit
is catalytic and suggested that the
subunit has regulatory
properties (13, 23-25).2 To directly assess the role of
each MAT subunit in enzyme activity, it was essential to express these
subunits in mammalian cells to ensure proper post-translational
modification and to study whether these subunits associate and
determine the consequence of this association on the kinetic properties
of MAT II.
2 and
subunits of MAT II associate spontaneously and that this association alters the kinetic properties of the enzyme. nickel-agarose capture purification of the His-tagged r
2 subunit from COS-1
cells co-expressing r
2 and r
showed that the
subunit co-purified with the
2 subunit. Interestingly,
r
2 oligomerized also with the endogenous
2 and
2' subunits, suggesting
heterologous oligomerization of
2,
2', and
subunits of MAT II. The consequence of the differential oligomerization remains under investigation, but it is noteworthy that
in cells expressing abundant amounts of r
2 and low
levels of endogenous
subunit, we could detect two kinetic forms of MAT II with Km values for L-Met of 17 and 75 µM. By contrast, in cells co-expressing
r
2 and r
, only one kinetic form of MAT II was
detected with a Km for L-Met of 20 µM. We believe that the lower Km form
represents oligomers of
2/
2' and
, and
the higher Km form found in cells overexpressing r
2 protein represents homo-oligomeric
2
subunits, which are in great excess of the endogenous
subunit. This
conclusion is consistent with our previous findings that the
Km for r
2 is 80 µM
(24)2 and that in physiologically stimulated peripheral
blood mononuclear cells, where the expression of the
subunit is
down-regulated and only the
2 subunit is expressed, the
Km for L-Met shifts from 20 µM to 55-67 µM (25).
subunit
associates with the
2 subunit and lowers the
Km for L-Met. The association between
the
2 and
subunit does not appear to require
metabolically active cells, since it occurs spontaneously when purified
r
2 and r
protein were mixed; however, the molar ratio
of each subunit in the holoenzyme remains to be determined. We
hypothesize, based on our data, that
2 can exist as
homo-oligomers (dimers or tetramers) or as
2/
hetero-oligomers. The relative ratio of either form would depend on the
relative molar concentration of
2 to
subunits, which
as we had previously reported can vary at different stages of
lymphocyte activation (25). We believe that this may be an important
mechanism by which MAT II can change its kinetic properties to
synthesize different amounts of AdoMet, because in addition to its
effect on lowering the Km for L-Met, the
subunit renders the enzyme more sensitive to AdoMet feedback inhibition.
subunit expression in
activated lymphocytes results in 5-fold higher AdoMet levels in these
cells (25). In these physiologically stimulated cells, the
subunit
disappears after 72 h, and the
2/
2'
subunits retain MAT activity with a Km for
L-Met of 55-67 µM and are at least 2-fold
more resistant to AdoMet feedback inhibition. As a result, there is an
accumulation of higher amounts of intracellular AdoMet, reaching up to
100 µM compared with resting lymphocyte levels of 20 µM. Although we have not fully deciphered the physiologic importance of this observation, it is interesting to note that certain
methyltransferases, including specific DNA methyltransferases that have
a relatively high Km for AdoMet (26, 34) may be more
active at the concentration attained in cells expressing only MAT II
2 subunits.
2 and
subunits alters the kinetic and regulatory properties of the enzyme. We believe that this mode of regulation is
important for adjusting the levels of AdoMet to meet the cellular requirements at different stages of differentiation and that this may
be needed to regulate the expression of certain genes and/or the
function of gene products.
![]()
FOOTNOTES
![]()
ABBREVIATIONS
2, recombinant
2;
r
, recombinant
;
AdoMet, S-adenosylmethionine;
PAGE, polyacrylamide gel
electrophoresis.
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1.
Cantoni, G. L.
(1953)
J. Biol. Chem.
204,
403-416 2.
Tabor, C. W.,
and Tabor, H.
(1984)
Adv. Enzymol. Relat. Areas Mol. Biol.
56,
251-282[Medline]
[Order article via Infotrieve]
3.
Kotb, M.,
and Geller, A. M.
(1993)
Pharmacol. Ther.
59,
125-43[CrossRef][Medline]
[Order article via Infotrieve]
4.
Chiang, P. K.,
Gordon, R. K.,
Tal, J.,
Zeng, G. C.,
Doctor, B. P.,
Pardhasaradhi, K.,
and McCann, P. P.
(1996)
FASEB J.
10,
471-480[Abstract]
5.
Mato, J. M.,
Alvarez, L.,
Ortiz, P.,
and Pajares, M. A.
(1997)
Pharmacol. Ther.
73,
265-80[CrossRef][Medline]
[Order article via Infotrieve]
6.
Finkelstein, J. D.,
Kyle, W. E.,
Martin, J. L.,
and Pick, A. M.
(1975)
Biochem. Biophys. Res. Commun.
66,
81-87[CrossRef][Medline]
[Order article via Infotrieve]
7.
Hoffman, J. L.
(1983)
Methods Enzymol.
94,
223-228[Medline]
[Order article via Infotrieve]
8.
Mudd, S. H.,
Levy, H. L.,
and Skovby, F.
(1995)
in
The Molecular and Metabolic Basis of Inherited Diseases
(Scriver, C. R.
, Beaudet, A. L.
, Sly, W. S.
, and Valle, D., eds), 7th Ed.
, McGraw-Hill Inc., New York
9.
Mato, J. M.,
Alvarez, L.,
Ortiz, P.,
Mingorance, J.,
Duran, C.,
and Pajares, M. A.
(1994)
Adv. Exp. Med. Biol.
368,
113-117[Medline]
[Order article via Infotrieve]
10.
Okada, G.,
Teraoka, H.,
and Tsukada, K.
(1981)
Biochemistry
20,
934-940[CrossRef][Medline]
[Order article via Infotrieve]
11.
Kotb, M.,
Mudd, S. H.,
Mato, J. M.,
Geller, A. M.,
Kredich, N. M.,
Chou, J. Y.,
and Cantoni, G. L.
(1997)
Trends Genet.
13,
51-52[CrossRef][Medline]
[Order article via Infotrieve]
12.
Oden, K.,
and Clarke, S.
(1983)
Biochemistry
22,
2978-2986[CrossRef][Medline]
[Order article via Infotrieve]
13.
Kotb, M.,
and Kredich, N. M.
(1985)
J. Biol. Chem.
260,
3923-3930 14.
Langkamp-Henken, B.,
Geller, A. M.,
LeGros, H. L., Jr.,
Price, J. O.,
De la Rosa, J.,
and Kotb, M.
(1994)
Biochim. Biophys. Acta
1201,
397-404[Medline]
[Order article via Infotrieve]
15.
Liau, M. C.,
Chang, C. F.,
Belanger, L.,
and Grenier, A.
(1979)
Cancer Res.
39,
162-169 16.
Sullivan, D. M.,
and Hoffman, J. L.
(1983)
Biochemistry
22,
1636-1641[CrossRef][Medline]
[Order article via Infotrieve]
17.
Mitsui, K.,
Teraoka, H.,
and Tsukada, K.
(1988)
J. Biol. Chem.
263,
11211-11216 18.
Horikawa, S.,
Sasuga, J.,
Shimizu, K.,
Ozasa, H.,
and Tsukada, K.
(1990)
J. Biol. Chem.
265,
13683-13686 19.
Horikawa, S.,
and Tsukada, K.
(1991)
Biochem. Int.
25,
81-90[Medline]
[Order article via Infotrieve]
20.
Alvarez, L.,
Corrales, F.,
Martin-Duce, A.,
and Mato, J. M.
(1993)
Biochem. J.
293,
481-486
21.
Sakata, S. F.,
Shelly, L. L.,
Ruppert, S.,
Schutz, G.,
and Chou, J. Y.
(1993)
J. Biol. Chem.
268,
13978-13986 22.
Ubagai, T.,
Lei, K. J.,
Huang, S.,
Mudd, S. H.,
Levy, H. L.,
and Chou, J. Y.
(1995)
J. Clin. Invest.
96,
1943-1947
23.
De La Rosa, J.,
LeGros, H. L., Jr.,
Geller, A. M.,
and Kotb, M.
(1992)
J. Biol. Chem.
267,
10699-10704 24.
De La Rosa, J.,
Ostrowski, J.,
Hryniewicz, M. M.,
Kredich, N. M.,
Kotb, M.,
LeGros, H. L., Jr.,
Valentine, M.,
and Geller, A. M.
(1995)
J. Biol. Chem.
270,
21860-21868 25.
LeGros, H. L., Jr.,
Geller, A. M.,
and Kotb, M.
(1997)
J. Biol. Chem.
272,
16040-16047 26.
Roth, M.,
Helm-Kruse, S.,
Friedrich, T.,
and Jeltsch, A.
(1998)
J. Biol. Chem.
273,
17333-17342 27.
De La Rosa, J.,
Kotb, M.,
and Kredich, N. M.
(1991)
Biochim. Biophys. Acta
1077,
225-232[CrossRef][Medline]
[Order article via Infotrieve]
28.
Kotb, M.,
Geller, A. M.,
Markham, G. D.,
Kredich, N. M.,
De La Rosa, J.,
and Beachey, E. H.
(1990)
Biochim. Biophys. Acta
1040,
137-144[CrossRef][Medline]
[Order article via Infotrieve]
29.
Mingorance, J.,
Alvarez, L.,
Pajares, M. A.,
and Mato, J. M.
(1997)
Int. J. Biochem. Cell Biol.
29,
485-491[CrossRef][Medline]
[Order article via Infotrieve]
30.
Suma, Y.,
Shimizu, K.,
and Tsukada, K.
(1986)
J. Biochem. (Tokyo)
100,
67-75 31.
Pajares, M. A.,
Corrales, F.,
Duran, C.,
Mato, J. M.,
and Alvarez, L.
(1992)
FEBS Lett.
309,
1-4[CrossRef][Medline]
[Order article via Infotrieve]
32.
Corrales, F.,
Cabrero, C.,
Pajares, M. A.,
Ortiz, P.,
Martin-Duce, A.,
and Mato, J. M.
(1990)
Hepatology
11,
216-222[Medline]
[Order article via Infotrieve]
33.
Corrales, F.,
Ochoa, P.,
Rivas, C.,
Martin-Lomas, M.,
Mato, J. M.,
and Pajares, M. A.
(1991)
Hepatology
14,
528-533[CrossRef][Medline]
[Order article via Infotrieve]
34.
Fujioka, M.
(1992)
Int. J. Biochem.
24,
1917-1924[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R. R. Attia, L. A. Gardner, E. Mahrous, D. J. Taxman, L. LeGros, S. Rowe, J. P.-Y. Ting, A. Geller, and M. Kotb Selective Targeting of Leukemic Cell Growth in Vivo and in Vitro Using a Gene Silencing Approach to Diminish S-Adenosylmethionine Synthesis J. Biol. Chem., November 7, 2008; 283(45): 30788 - 30795. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Kim, S. L. Coon, S. Blackshaw, C. L. Cepko, M. Moller, S. Mukda, W.-Q. Zhao, C. G. Charlton, and D. C. Klein Methionine Adenosyltransferase:Adrenergic-cAMP Mechanism Regulates a Daily Rhythm in Pineal Expression J. Biol. Chem., January 7, 2005; 280(1): 677 - 684. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yang, M. R. Sadda, V. Yu, Y. Zeng, T. D. Lee, X. Ou, L. Chen, and S. C. Lu Induction of Human Methionine Adenosyltransferase 2A Expression by Tumor Necrosis Factor {alpha}: ROLE OF NF-{kappa}B AND AP-1 J. Biol. Chem., December 19, 2003; 278(51): 50887 - 50896. [Abstract] [Full Text] [PDF] |
||||
![]() |